The cytokine-induced C-C chemokine monocyte chemoattractant protein-1 (MCP-
1) is an important regulator of leukocyte recruitment to sites of inflammat
ory challenge. Here, it is demonstrated that the widely distributed contact
hapten NiCl2, like tumor necrosis factor a (TNF alpha), induces monocyte-c
hemoattractant activity in primary human endothelial cells via induction of
MCP-1, NiCl2 rapidly activated mitogen-activated protein (MAP) kinase p38,
and inhibition of p38 partially blocked NiCl2-induced MCP-1 messenger RNA
and protein expression. Both NiCl2- and TNF alpha -induced MCP-1 synthesis
was sensitive to D609, an inhibitor of phosphatidylcholine-dependent phosph
olipase C (PC-PLCl. NiCl2-induced MCP-1 synthesis required activation of NF
-kappaB since mutation of NF-kappaB-binding sites in the promoter resulted
in complete loss of inducible promoter activity. Consistent with that findi
ng, stimulation with NiCl2 or TNF alpha activated I kappaB kinase-p (IKK be
ta), and transient transfection of dominant-negative IKK beta strongly inhi
bited NiCl2- and TNF alpha -induced MCP-I expression. However, D609 and the
specific p38 inhibitor SB202190 did not affect NiCl2- and TNF alpha -induc
ed IKK beta activation, NF-kappaB DNA-binding activity, or transcriptional
activity of a Gal4p65 fusion protein. This indicates that p38- and PC-PLC-d
ependent pathways directly regulate the transcriptional activity of NF-kapp
aB factors in the transcriptional complex, Consistent with that, inhibition
of p38 blocked enhanced transcriptional activity induced by the transcript
ional coactivator p300. Thus, it was concluded that at least 3 independent
pathways regulate MCP-1 expression in endothelial cells, Its Induction requ
ires activation of the IKK beta /1 kappaB alpha /NF-kappaB signaling pathwa
y, resulting In nuclear accumulation of p65 and subsequent recruitment of c
ofactors. Proper assembly and activity of this transcriptional complex is f
urther modulated by the p38 MAP kinase cascade and a PC-PLC-dependent pathw
ay. (C) 2001 by the American Society of Hematology.